Author: Karl Williams, JD, MBA, BS '80
Clinical Professor and Director of Professional Affairs
Editor, Pharmacy Law
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
In early 2025 two bills[1] concerning prescription labeling requirements were enacted by the signature of Gov. Kathy Hochul. Each of these amended the state pharmacy practice law requirement that the name of the prescriber is included on the label provided to the patient. The new law provides for a measure of protection for practitioners prescribing or dispensing mifepristone and/or misoprostil.
Civil and criminal charges have been preferred against New York licensed prescribers caring for patients in states that have outlawed the use of mifepristone and/or misoprostol to terminate pregnancy. The new law gives the dispensing pharmacy legal protection for, at the request of the prescriber, inserting the name or address of the practitioner’s practice instead of the practitioner themselves.[2]
Typically, the prescriber’s name is required on the label, or the dispenser would face criminal misdemeanor charges[3] and administrative liability against their professional license. The new law provided the same authority for prescribers who dispense directly to patients.[4]
In late 2025, New York enacted what has come to be known as Shield Law 2.0 designed to provide legal protection to health care providers who would face liability for providing reproductive health care.[5] To summarize, this law provides legal protection from out-of-state charges for civil and criminal liability, subpoenas and other requests for information, and restricts release patient information related to reproductive health, and services.
[1] Laws of New York 2025, Chapter 7, followed by Laws of New York 2025, Chapter 108.
[2] Education Law 6810(1-a).
[3] Education Law §6811(19) and §6509(5).
[4] Education Law §6807(b-1).
[5] Also gender-affirming care. Laws of New York 2025, Chapter 694.
Copyright © 2026 University at Buffalo. All rights reserved.
Pharmacy Law is published as an educational service to the pharmacy community in New York State. Its sole purpose is to promote an understanding of the laws, rules, and regulations that affect the practice of pharmacy in New York. The advisory board, authors and the University at Buffalo do not hold themselves out as offering legal advice. Readers should seek counsel for specific legal questions or concerns.